0001599298-24-000058.txt : 20240404
0001599298-24-000058.hdr.sgml : 20240404
20240404174715
ACCESSION NUMBER: 0001599298-24-000058
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240402
FILED AS OF DATE: 20240404
DATE AS OF CHANGE: 20240404
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Anand Bhaskar
CENTRAL INDEX KEY: 0001890784
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36866
FILM NUMBER: 24824205
MAIL ADDRESS:
STREET 1: 5320 LEGACY DRIVE
CITY: PLANO
STATE: TX
ZIP: 75024
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Summit Therapeutics Inc.
CENTRAL INDEX KEY: 0001599298
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 2882 SAND HILL ROAD
STREET 2: SUITE 106
CITY: MENLO PARK
STATE: CA
ZIP: 94025
BUSINESS PHONE: 650-460-8308
MAIL ADDRESS:
STREET 1: 2882 SAND HILL ROAD
STREET 2: SUITE 106
CITY: MENLO PARK
STATE: CA
ZIP: 94025
FORMER COMPANY:
FORMER CONFORMED NAME: Summit Therapeutics plc
DATE OF NAME CHANGE: 20150219
FORMER COMPANY:
FORMER CONFORMED NAME: Summit Corp plc
DATE OF NAME CHANGE: 20140205
4
1
wk-form4_1712267219.xml
FORM 4
X0508
4
2024-04-02
0
0001599298
Summit Therapeutics Inc.
SMMT
0001890784
Anand Bhaskar
C/O SUMMIT THERAPEUTICS INC.
601 BRICKELL KEY DRIVE, SUITE 1000
MIAMI
FL
33131
0
1
0
0
Chief Accounting Officer
0
Stock Option (right to buy)
3.85
2024-04-02
4
A
0
600000
A
2034-04-02
Common Stock
600000
600000
D
The option was granted on April 2, 2024. The shares underlying the option shall vest in four equal annual installments, with the first such installment occurring on April 2, 2025. Note this does not include an additional 600,000 options which were granted on April 2, 2024 and are subject to the satisfaction of performance conditions based on market capitalization and revenue targets.
Not applicable.
/s/ Bhaskar Anand
2024-04-04